학술논문

Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma.
Document Type
Article
Source
Investigational New Drugs; Jun2013, Vol. 31 Issue 3, p769-773, 5p
Subject
ANTINEOPLASTIC agents
ACADEMIC medical centers
CLINICAL trials
ENZYME-linked immunosorbent assay
MELANOMA
METASTASIS
RESEARCH funding
T-test (Statistics)
DESCRIPTIVE statistics
INVESTIGATIONAL drugs
PHARMACODYNAMICS
Language
ISSN
01676997